The global burden of XDR-TB is concentrated in certain high-burden countries, with significant variations in prevalence and incidence rates. Surveillance and reporting mechanisms have improved over the years, providing better estimates of the disease's spread. However, underreporting and misdiagnosis remain issues in many regions, complicating efforts to quantify and address the epidemic accurately.
